WADA comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-06. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Free water The bulk of water contained in the cell lumina is only held by capillary forces. It is not bound chemically and is called free water. Free water is not in the same thermodynamic state as liquid water: energy is required to overcome the capillary forces. Furthermore, free water may contain chemicals, altering the drying characteristics of wood. Bound or hygroscopic water Bound water is bound to the wood via hydrogen bonds. The attraction of wood for water arises from the presence of free hydroxyl (OH) groups in the cellulose, hemicelluloses and lignin molecules in the cell wall. The hydroxyl groups are negatively charged. Because water is a polar liquid, the free hydroxyl groups in cellulose attract and hold water by hydrogen bonding. Vapor Water in cell lumina in the form of water vapour is normally negligible at normal temperature and humidity.
During Operation Moduler, Cuban combat troops had remained well north of the Lomba River and declined to participate in the fighting, per Castro's instructions. In Luanda, President dos Santos summoned General Gusev and the senior Cuban general officer, Gustavo Fleitas Ramirez, for an urgent conference to discuss the worsening military situation and the failure of Operation Saluting October. Ramirez reminded dos Santos that Cuba had been opposed to the offensive from the beginning. Gusev lamented in his memoirs that "I informed [chief of the Soviet general staff] Akhromeyev about the result of the operation, but the most difficult task, in moral terms, was to inform the president of Angola, whom I had assured that the operation would succeed and that Savimbi would be crushed". On 25 November 1987, United Nations Security Council Resolution 602 was passed, condemning Operation Moduler as an illegal violation of Angolan sovereignty. The resolution expressed dismay at the continued presence of SADF troops in Angola and called for their unconditional withdrawal. South African foreign minister Pik Botha flatly dismissed the resolution out of hand, citing the unaddressed issue of Cuban linkage. He promised that the SADF would depart Angola once FAPLA's Cuban and Soviet advisers had likewise been withdrawn, or when their presence no longer threatened South African interests.
nicking enzyme Also nicking endonuclease and nickase. Any of a class of endonuclease enzymes capable of generating a single-stranded break in a double-stranded DNA molecule, i.e. a nick, either at random or at a specific recognition sequence, by breaking a phosphodiester bond linking adjacent nucleotides.
There were almost 18.3 million connections to the Internet in June 2014. According to Bloomberg, in 2013 Romania ranked fifth in the world, and according to The Independent, it ranks number one in Europe at Internet speeds, with Timișoara ranked among the highest in the world.
Sources: en.wikipedia.org
Besides the Pidgeon process, the second most used process for magnesium production is electrolysis. This is a two step process. The first step is to prepare feedstock containing magnesium chloride and the second step is to dissociate the compound in electrolytic cells as magnesium metal and chlorine gas. To extract the magnesium, calcium hydroxide is added to the seawater to precipitate magnesium hydroxide.
Most of the proteins in food responsible for the immune reaction in coeliac disease are prolamins. These are storage proteins rich in proline (prol-) and glutamine (-amin) that dissolve in alcohols and are resistant to proteases and peptidases of the gut. Prolamins are found in cereal grains with different grains having different but related prolamins: wheat (gliadin), barley (hordein), rye (secalin) and oats (avenin).
Monsanto did not take up the challenge but stated that GM food did indeed undergo safety assessments that "are more rigorous and thorough than assessments of any other food crop in history". In 2016, Ayyadurai promised to donate $10 million to Hillary Clinton's presidential campaign if she could disprove his research.
=== Blended grain === The term blended grain Scotch refers to whisky that contains at least two single grain Scotch whiskies from at least two distilleries, combined to create one batch of the product.
== Single-player mods == Aperture Tag - A modification based on Portal 2 that recreates the essence of the game Tag: The Power of Paint, the inspiration for the various gels used in Portal 2. Instead of a portal gun, the player solves puzzles using a mix of these gels that they can spray onto surfaces with a tool they carry. Black Mesa - A third-party recreation of Half-Life (1998) that was made in response to the release of Half-Life: Source (2004), a port of the original game to the Source engine. Black Mesa originally released as a free mod in September 2012, and later had a full commercial release on Steam in March 2020. Coastline to Atmosphere - A mod set in the Half-Life 2 universe, following Gordon Freeman after the events of Half-Life 2. Dear Esther - An experimental "ghost story" created as a research project at the University of Portsmouth; initially released as a free modification in 2008, a longer commercial version was developed and released in 2012. Entropy: Zero - A Half-Life 2 modification developed by Breadman set before the base game's story in which a Combine Civil Protection officer, named "Bad Cop", becomes stranded in City 10. Entropy: Zero - Uprising - A mod of Entropy: Zero developed by Employee8 and Filipad that takes place during the uprising in Half-Life 2. Entropy: Zero 2 - A sequel to Entropy: Zero. Set post-Half-Life 2, its story follows Bad Cop, who has been promoted to "Elite" status, as he works to capture Dr. Judith Mossman, the former assistant of Earth's Administrator.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.